Hiramatsu, Hiroaki
Yokomori, Rui
Shengyi, Liu
Tanaka, Norio http://orcid.org/0000-0003-2724-8009
Mori, Seiichi
Kiyotani, Kazuma http://orcid.org/0000-0002-9236-9061
Gotoh, Osamu http://orcid.org/0000-0002-9363-4584
Kusumoto, Shigeru
Nakano, Nobuaki http://orcid.org/0000-0001-9826-7616
Suehiro, Youko
Ito, Asahi
Choi, Ilseung
Ohtsuka, Eiichi
Hidaka, Michihiro
Nosaka, Kisato
Yoshimitsu, Makoto http://orcid.org/0000-0002-5935-0385
Imaizumi, Yoshitaka
Iida, Shinsuke
Utsunomiya, Atae http://orcid.org/0000-0002-8843-406X
Noda, Tetsuo
Nishikawa, Hiroyoshi http://orcid.org/0000-0001-6563-9807
Ueda, Ryuzo
Sanda, Takaomi http://orcid.org/0000-0003-1621-4954
Ishida, Takashi http://orcid.org/0000-0002-1060-0777
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP16cm0106301, JP17cm0106301, JP18cm0106301, JP19cm0106301, JP20cm0106301, JP21cm0106301, 20ae0101074h0001, 21ae0101074h0001, 22ae0101074h0001)
MEXT | Japan Society for the Promotion of Science (21K19900, 22H02918)
Article History
Received: 11 January 2023
Revised: 24 September 2023
Accepted: 4 October 2023
First Online: 20 October 2023
Competing interests
: SK received research funding from Chugai, Daiichi-Sankyo, and honoraria from Chugai, Kyowa Kirin. NN received honoraria from Novartis, Takeda, Chugai, Celgene, Otsuka, Nippon Shinyaku, Kyowa Kirin, Asahi-Kasei, and consulting fees from JIMRO. YS received research funding from Chugai, Novartis, Bayer, Eisai, Ono, Otsuka, Pfizer, Amgen, Daiichi Sankyo, Celgene, and Incyte. MH received honoraria from Chugai, and consulting fees from Symbio. KN received research funding from Chugai, Kyowa Kirin, and honoraria from Meiji Seika, Celgene, Eisai, Novartis and had a Consultant or advisory role from Kyowa Kirin. MY received honoraria from Novartis, Takeda, and consulting fees from Takeda. YI received honoraria from Bristol-Myers, Celgene, CHUGAI, Eisai, Kyowa Kirin, Meiji Seika, Nippon Shinyaku, Sanofi, SymBio, Sumitomo Dainippon. SI received honoraria and research grants from Janssen, Sanofi, Takeda, Ono, Celgene, Bristol-Myers Squibb, and Daiichi-Sankyo, also received research grants from Novartis, Pfizer, Amgen, Caelum, Abbvie, Glaxo-Smithklein, Chugai and Kyowa Kirin. Atae Utsunomiya received honoraria from Kyowa Kirin, Daiichi-Sankyo, Bristol-Myers, and consulting fees from HUYA Japan, JIMRO, Meiji Seika and Otsuka Medical Devices. HN received research funding and honoraria from Ono, Bristol-Myers, MSD, Chugai, and research funding from Taiho, Daiichi-Sankyo, Kyowa Kirin, Zenyaku, Oncolys BioPharma, Debiopharma, Asahi-Kasei, Sysmex, Fujifilm, SRL, Astellas, Sumitomo Dainippon and BD Japan outside of this study. RU received research funding from Kyowa Kirin, Chugai Pharmaceutical, and Ono. The other authors have no COI to disclose.